ULTRAVATE (halobetasol propionate 0.05% lotion
SELF ADMINISTRATION
FDA Approved Indications:
- Topical treatment of plaque psoriasis in patients 18 years of age and older
Prior authorization criteria:
- Patient has a diagnosis of plaque psoriasis, AND
- Patient is 18 years of age or older, AND
- Patient has tried and failed the halobetasol cream
Dosing:
- Apply a thin layer to affected areas twice daily
- Limit use to 50 g/week
- Discontinue when control is achieved
- If no improvement is seen within 2 weeks, reassess diagnosis
- Treatment beyond 2 consecutive weeks is not recommended
- Avoid use on face, scalp, groin or axillae
Approval:
- Limited to a maximum of 2 weeks